Narwhal Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-16,890
| Closed | -$612K | – | 147 |
|
|
2016
Q4 | $612K | Sell |
16,890
-55,120
| -77% | -$2M | 0.18% | 102 |
|
|
2016
Q3 | $3.31M | Sell |
72,010
-500
| -0.7% | -$23K | 1.04% | 27 |
|
|
2016
Q2 | $3.64M | Buy |
72,510
+17,660
| +32% | +$887K | 1.14% | 25 |
|
|
2016
Q1 | $2.94M | Buy |
54,850
+11,400
| +26% | +$610K | 0.96% | 33 |
|
|
2015
Q4 | $2.85M | Hold |
43,450
| – | – | 0.99% | 32 |
|
|
2015
Q3 | $2.45M | Hold |
43,450
| – | – | 0.92% | 37 |
|
|
2015
Q2 | $2.57M | Hold |
43,450
| – | – | 0.93% | 34 |
|
|
2015
Q1 | $2.71M | Buy |
43,450
+1,980
| +5% | +$123K | 0.99% | 31 |
|
|
2014
Q4 | $2.39M | Buy |
41,470
+200
| +0.5% | +$11.5K | 0.92% | 35 |
|
|
2014
Q3 | $2.22M | Sell |
41,270
-13,450
| -25% | -$723K | 0.89% | 37 |
|
|
2014
Q2 | $2.87M | Sell |
54,720
-1,230
| -2% | -$64.5K | 1.1% | 23 |
|
|
2014
Q1 | $2.96M | Hold |
55,950
| – | – | 1.23% | 15 |
|
|
2013
Q4 | $2.24M | Buy |
55,950
+6,300
| +13% | +$252K | 0.92% | 32 |
|
|
2013
Q3 | $1.88M | Buy |
49,650
+3,900
| +9% | +$147K | 0.9% | 42 |
|
|
2013
Q2 | $1.79M | Buy |
+45,750
| New | +$1.79M | 0.87% | 43 |
|